ES2078501T3 - Metodo para el tratamiento de la trombocitopenia y composiciones farmaceuticas utiles para el mismo. - Google Patents

Metodo para el tratamiento de la trombocitopenia y composiciones farmaceuticas utiles para el mismo.

Info

Publication number
ES2078501T3
ES2078501T3 ES91900679T ES91900679T ES2078501T3 ES 2078501 T3 ES2078501 T3 ES 2078501T3 ES 91900679 T ES91900679 T ES 91900679T ES 91900679 T ES91900679 T ES 91900679T ES 2078501 T3 ES2078501 T3 ES 2078501T3
Authority
ES
Spain
Prior art keywords
treatment
pharmaceutical compositions
thrombocitopenia
same
compositions useful
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES91900679T
Other languages
English (en)
Inventor
Donald Metcalf
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
CSL Innovation Pty Ltd
Original Assignee
Amrad Corp Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amrad Corp Ltd filed Critical Amrad Corp Ltd
Application granted granted Critical
Publication of ES2078501T3 publication Critical patent/ES2078501T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A61K38/2093—Leukaemia inhibitory factor [LIF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

METODO PARA EL TRATAMIENTO DE LA TROMBOCITOPENIA Y COMPOSICIONES FARMACEUTICAS UTILES PARA EL MISMO LA PRESENTE INVENCION SE REFIERE, EN GENERAL, A UN METODO, Y A COMPOSICIONES FARMACEUTICAS UTILES, PARA EL TRATAMIENTO DE LA TROMBOCITOPENIA EN UN MAMIFERO MEDIANTE LA ADMINISTRACION DE UNA CANTIDAD EFECTIVA DEL FACTOR INHIBIDOR DE LA LEUCEMIA (LIF) Y/O SUS DERIVADOS Y OPCIONALMENTE EN COMBINACION CON UNA O MAS CITOQUINAS.
ES91900679T 1989-12-18 1990-12-18 Metodo para el tratamiento de la trombocitopenia y composiciones farmaceuticas utiles para el mismo. Expired - Lifetime ES2078501T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AUPJ791289 1989-12-18
AUPK350190 1990-11-23

Publications (1)

Publication Number Publication Date
ES2078501T3 true ES2078501T3 (es) 1995-12-16

Family

ID=25643793

Family Applications (1)

Application Number Title Priority Date Filing Date
ES91900679T Expired - Lifetime ES2078501T3 (es) 1989-12-18 1990-12-18 Metodo para el tratamiento de la trombocitopenia y composiciones farmaceuticas utiles para el mismo.

Country Status (12)

Country Link
US (1) US5571508A (es)
EP (1) EP0506716B1 (es)
JP (1) JP2574962B2 (es)
AT (1) ATE128871T1 (es)
CA (1) CA2071956C (es)
DE (1) DE69023006T2 (es)
DK (1) DK0506716T3 (es)
ES (1) ES2078501T3 (es)
FI (1) FI922839A (es)
GR (1) GR3017727T3 (es)
HU (2) HUT61485A (es)
WO (1) WO1991008752A1 (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2338897A1 (en) 1995-06-07 2011-06-29 Glaxo Group Limited Peptides and compounds that bind to a thrombopoietin receptor
US6251864B1 (en) 1995-06-07 2001-06-26 Glaxo Group Limited Peptides and compounds that bind to a receptor
US5869451A (en) * 1995-06-07 1999-02-09 Glaxo Group Limited Peptides and compounds that bind to a receptor
US7091311B2 (en) 1996-06-07 2006-08-15 Smithkline Beecham Corporation Peptides and compounds that bind to a receptor
ES2781475T3 (es) 2002-09-18 2020-09-02 Janssen Pharmaceuticals Inc Métodos para aumentar la producción de células madre hematopoyéticas y plaquetas
PT1675606T (pt) 2003-08-28 2017-05-22 Janssen Pharmaceuticals Inc Péptidos e compostos que se ligam a um receptor
US7723295B2 (en) 2003-08-28 2010-05-25 Ortho-Mcneil Pharmaceutical, Inc. Peptides and compounds that bind to a receptor

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4859648A (en) * 1984-12-28 1989-08-22 Mobil Oil Corporation Layered metal chalcogenides containing interspathic polymeric chalcogenides
AU609128B2 (en) * 1987-04-02 1991-04-26 Amrad Operations Pty. Limited Leukaemia-inhibitory factor
WO1990002183A1 (en) * 1988-08-18 1990-03-08 Genetics Institute, Inc. Production of a novel lymphokine exhibiting differentiation inhibitory activity
JP2805224B2 (ja) * 1989-01-13 1998-09-30 味の素株式会社 血小板減少症治療剤
ATE138267T1 (de) * 1989-11-24 1996-06-15 Univ Monash Proliferative wirkung des leukämie- hemmungsfaktors auf satellitzellen

Also Published As

Publication number Publication date
HUT61485A (en) 1993-01-28
FI922839A0 (fi) 1992-06-17
HU9202026D0 (en) 1992-09-28
JPH05502667A (ja) 1993-05-13
ATE128871T1 (de) 1995-10-15
AU6910491A (en) 1991-07-18
US5571508A (en) 1996-11-05
WO1991008752A1 (en) 1991-06-27
HU210882A9 (en) 1995-09-28
EP0506716A4 (en) 1993-05-05
GR3017727T3 (en) 1996-01-31
CA2071956C (en) 2000-04-18
AU644834B2 (en) 1993-12-23
EP0506716A1 (en) 1992-10-07
JP2574962B2 (ja) 1997-01-22
DE69023006T2 (de) 1996-04-11
EP0506716B1 (en) 1995-10-11
DK0506716T3 (da) 1996-02-26
FI922839A (fi) 1992-06-17
DE69023006D1 (de) 1995-11-16
CA2071956A1 (en) 1991-06-19

Similar Documents

Publication Publication Date Title
GT199900150A (es) 1,2,3,4-tetrahidroquinolinas 2-sustituidas 4-carboxiamino sustituidas.
MX9306986A (es) Composiciones farmaceuticas a base de taxoides.
AR091405A2 (es) Omega-carboxiaril difenil urea sustituida con fluoro y composiciones farmaceuticas que las contienen
CO4290353A1 (es) Agonistas de estrogeno
ES2040838T3 (es) Compuestos piperazinil-heterociclicos.
AR005703A1 (es) Oxazolidinonas sustituidas, procedimiento para su preparacion, uso de las mismas para preparar medicamentos y medicamentos que las contienen
CY1114692T1 (el) Εστερες στη θεση 20 των καμπτοθεκινων
ES2076688T3 (es) Derivados de 2-hidroxi-2-feniletilamina utiles como agonistas de beta-3-adrenoceptores.
ES2186667T3 (es) Analogos de nucleosidos de 1,3-oxatiolano.
ES2038756T3 (es) Dihidrato de azitromicina.
HN1993004031A (es) N - (4,6 dime) amin - 3 tri - 2 sulfo o una de sus sales utiles composicion herbicida que contiene el mismo y proceso para la produccion del compuesto.
ES2083668T5 (es) Combinaciones antiviricas que contienen analogos de nucleosido.
IT7830205A0 (it) Derivati di 1,3,4,5-tetraidrobenz-indolo erelativo procedimento per fabbricarli.
DK0530087T3 (da) Hidtil ukendte naphthylethylurinstof- og naphthylethylthiourinstofforbindelser, fremgangsmåde til fremstilling heraf og farmaceutiske midler, som indeholder dem
PA8432901A1 (es) Compuestos de piridilpirrol
IT9047565A1 (it) Composizioni stabilizzanti a base di derivati del fosforo.
DK10488A (da) Benzen-derivater med antiinflammatorisk virkning og fremgangsmaade til fremstilling deraf
CY1108793T1 (el) Καμπτοθεκινες με τροποποιημενο λακτονικο δακτυλιο
ES2078501T3 (es) Metodo para el tratamiento de la trombocitopenia y composiciones farmaceuticas utiles para el mismo.
ES2057679T3 (es) Piridinas substituidas.
ECSP034532A (es) Derivados del 1-aminobutan-3-ol sustituido
ES2042726T3 (es) Beta-alquilmelatoninas.
ES2155091T3 (es) Procedimiento para la produccion de inhibidores de la proteasa del vih.
ES2104917T3 (es) Bis-naftalimidas que contienen engarces amido y tioamido como agentes anticancerosos.
ES2071458T3 (es) Nuevos compuestos amidicos de 1-(alcoxi-bencil)-piperacinas, sus procedimientos de preparacion y las composiciones farmaceuticas que los contienen.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 506716

Country of ref document: ES